Both dual bronchodilation and triple therapy demonstrated similar rates of mortality in patients with moderate to severe COPD at low risk for exacerbations. Both dual bronchodilation and triple ...
May 27, 2009 (San Diego, California) — The novel once-daily inhalation β 2-agonist indacaterol was well tolerated, had safety profiles similar to placebo (both at 150 μg and 300 μg doses), and ...
A new study in mice and human tissue shows that activation of bitter taste receptors in the airways relaxes airway smooth muscle, resulting in bronchodilation (pages 1299–1304). Agonists of these ...
The alternative text for this image may have been generated using AI. Figure 2: Lack of an effect of BK channel blockers on bitter tastant–induced relaxation in mouse intrapulmonary mainstem bronchi.